MAP3K19 and asthma: Our in vitro studies suggested that MAP3K19 is involved in type 2 inflammation and cellular EMT processes that may contribute to airway inflammation in patients with asthma; therefore, we investigated whether MAP3K19 knockout is involved in airway inflammation in a murine model of asthma.